Press Release: The Conference Exchange : ELBIT IMAGING ANNOUNCES DATA FROM GAMIDA CELL'S NAM-NK AND NICORD® PROGRAMS TO BE PRESENTED AT 2019 TCT ANNUAL MEETING

Tel Aviv, Israel, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit") announced today, further to its press releases dated December 3, 2018 and June 25, 2018, that Gamida Cell Ltd. (Nasdaq: GMDA) ("Gamida"), an indirect shareholding of the Company, has announced that new data from its clinical programs will be presented at the 2019 Transplantation & Cellular Therapy (TCT) Meeting of American Society for Blood and Marrow Transplantation (ASBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR) taking place in Houston, Texas, February 20-24.